Timothy L. Moore is Chief Technical Officer of Allogene Therapeutics, Inc.. Currently has a direct ownership of 265,459 shares of ALLO, which is worth approximately $618,519. The most recent transaction as insider was on Apr 22, 2024, when has been sold 17,360 shares (Common Stock) at a price of $3.47 per share, resulting in proceeds of $60,239. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 265K
6.14% 3M change
42.55% 12M change
Total Value Held $618,519

TIMOTHY L. MOORE Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 22 2024
SELL
Payment of exercise price or tax liability
$60,239 $3.47 p/Share
17,360 Reduced 6.14%
265,459 Common Stock
Jan 25 2024
BUY
Grant, award, or other acquisition
-
96,600 Added 25.46%
282,819 Common Stock
Apr 24 2023
BUY
Grant, award, or other acquisition
-
186,219 Added 50.0%
186,219 Common Stock

Also insider at

CERS
CERUS CORP Healthcare
BLFS
BIOLIFE SOLUTIONS INC Healthcare
TIL
Instil Bio, Inc. Healthcare
TLM

Timothy L. Moore

Chief Technical Officer
Bothell, WA

Track Institutional and Insider Activities on ALLO

Follow Allogene Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALLO shares.

Notify only if

Insider Trading

Get notified when an Allogene Therapeutics, Inc. insider buys or sells ALLO shares.

Notify only if

News

Receive news related to Allogene Therapeutics, Inc.

Track Activities on ALLO